MENU
+Compare
RXL
ETF ticker: NYSE ARCA
AS OF
Jun 25, 04:59 PM (EDT)
Price
$40.18
Change
-$0.08 (-0.20%)
Net Assets
65.21M

RXL stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P Health Care Select Sector Index... Show more

Category: #Trading
RXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for RXL with price predictions
Jun 24, 2025

RXL in -1.30% downward trend, declining for three consecutive days on June 20, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where RXL declined for three days, in of 289 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RXL as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

RXL moved below its 50-day moving average on June 17, 2025 date and that indicates a change from an upward trend to a downward trend.

RXL broke above its upper Bollinger Band on June 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for RXL just turned positive on June 24, 2025. Looking at past instances where RXL's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RXL advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 260 cases where RXL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV).

Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P Health Care Select Sector Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of health care companies included in the S&P 500 Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Market Cap

The average market capitalization across the ProShares Ultra Health Care ETF is 88.6B. The market cap for tickers in the group ranges from 8.13B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is TECH at 8.13B.

High and low price notable news

The average weekly price growth across all stocks in the ProShares Ultra Health Care ETF was 6%. For the same ETF, the average monthly price growth was 18%, and the average quarterly price growth was 53%. MRNA experienced the highest price growth at 6%, while AMGN experienced the biggest fall at -3%.

Volume

The average weekly volume growth across all stocks in the ProShares Ultra Health Care ETF was 11%. For the same stocks of the ETF, the average monthly volume growth was 16% and the average quarterly volume growth was 94%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 65
Price Growth Rating: 51
SMR Rating: 100
Profit Risk Rating: 66
Seasonality Score: 34 (-100 ... +100)
View a ticker or compare two or three
RXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Fundamentals
Details
Category
Trading--Leveraged Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com